PSTV
Plus Therapeutics·NASDAQ
--
--(--)
--
--(--)
PSTV fundamentals
Plus Therapeutics (PSTV) Revenue Breakdown: Q3 2025 Business & Regional Performance
Plus Therapeutics (PSTV) reported total revenue of 1.40M USD in Q3 2025, with its core business segment Grant contributing 100.00%. Regionally, Americas remained the largest market, accounting for 9.10% of total revenue. Explore Plus Therapeutics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Plus Therapeutics (PSTV) reported total revenue of 1.40M USD in Q3 2025, with its core business segment Grant contributing 100.00%. Regionally, Americas remained the largest market, accounting for 9.10% of total revenue. Explore Plus Therapeutics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Plus Therapeutics's earnings call?What guidance did Plus Therapeutics's management provide for the next earnings period?What is Plus Therapeutics's gross profit margin?What does Plus Therapeutics do and what are its main business segments?What is the revenue and EPS growth rate for Plus Therapeutics year over year?What factors drove the changes in Plus Therapeutics's revenue and profit?What were the key takeaways from Plus Therapeutics’s earnings call?What is Plus Therapeutics's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
